PharmaRoth Labs Stock Forecast for 2023 - 2025 - 2030
Updated on 05/16/2024
PharmaRoth Labs Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, PharmaRoth Labs's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next six years, experts predict that Fair Value will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$771.12 | Buy/Sell | $636.99 | 13.80% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$154.28 | Buy/Sell | $174.55 | 10.19% |
MRK Stock Forecast | Merck | Outperform |
2
|
$130.88 | Buy/Sell | $130.51 | 9.26% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.92 | Buy/Sell | $32.87 | 5.46% |
VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$440.64 | Buy/Sell | $457.59 | 3.76% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$967.98 | Buy/Sell | $961.26 | 8.47% |
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.11 | Buy/Sell | $58.15 | 22.42% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$173.71 | Buy/Sell | $220.47 | 26.65% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$151.22 | Buy/Sell | $245.24 | 43.83% |
BAX Stock Forecast | Baxter International Inc | Hold |
17
|
$35.17 | Buy/Sell | $44.86 | 25.11% |
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.02 | Buy/Sell | $11.73 | 8.89% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$272.22 | Buy/Sell | $284.08 | 10.20% |
CTLT Stock Forecast | Catalent | Hold |
15
|
$55.25 | Buy/Sell | $49.29 | 14.93% |
CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$59.92 | Buy/Sell | $87.92 | 56.88% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$37.62 | Buy/Sell | $55.60 | 59.49% |
BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.63 | Buy/Sell | $145.00 | 5.34% |
MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$217.17 | Buy/Sell | $315.92 | 77.74% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.10 | Buy/Sell | $44.75 | 32.89% |
NEOG Stock Forecast | Neogen | Outperform |
16
|
$13.41 | Buy/Sell | $37.00 | 26.77% |
CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$27.54 | Buy/Sell | $35.67 | 45.24% |
PharmaRoth Labs EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, PharmaRoth Labs's EPS has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
INDV Stock Forecast | Indivior PLC | Buy |
14
|
£13.52 | Buy/Sell | £28.89 | 128.77% |
TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$17.42 | Buy/Sell | $29.44 | 98.05% |
AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$42.74 | Buy/Sell | $69.00 | 45.06% |